Home › Funds › Citigroup Inc › VRTX
Citigroup Inc position in VRTX
VERTEX PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)727.37K sh
Reported value held$361.31M
Portfolio Weight0.13%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 655.61K | $118.92M | New |
| Q4 2021 | 768.37K | $168.74M | Add |
| Q1 2022 | 700.24K | $182.74M | Reduce |
| Q2 2022 | 566.68K | $159.68M | Reduce |
| Q3 2022 | 540.44K | $156.48M | Reduce |
| Q4 2022 | 501.40K | $144.79M | Reduce |
| Q1 2023 | 424.88K | $133.87M | Reduce |
| Q2 2023 | 495.50K | $174.37M | Add |
| Q3 2023 | 544.30K | $189.27M | Add |
| Q4 2023 | 626.49K | $254.91M | Add |
| Q1 2024 | 480.87K | $201.01M | Reduce |
| Q2 2024 | 528.11K | $247.53M | Add |
| Q3 2024 | 679.12K | $315.85M | Add |
| Q4 2024 | 580.37K | $233.71M | Reduce |
| Q1 2025 | 642.51K | $311.50M | Add |
| Q2 2025 | 653.68K | $291.02M | Add |
| Q3 2025 | 594.60K | $232.87M | Reduce |
| Q4 2025 | 586.73K | $266.00M | Reduce |
| Q1 2026 | 733.11K | $327.36M | Add |
| Q2 2026 | 727.37K | $361.31M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- BlackRock Inc 24.11M sh · $11.98B · Q2 2026
- Vanguard Group 24.11M sh · $10.93B · Q4 2025
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- Geode Capital Management 6.02M sh · $2.98B · Q2 2026
- Franklin Resources 3.35M sh · $1.66B · Q2 2026
- Wellington Management Group 3.25M sh · $1.61B · Q2 2026
- Morgan Stanley 3.24M sh · $1.61B · Q2 2026
- Bank of America Corp 3.04M sh · $1.51B · Q2 2026
- Norges Bank Investment Management 2.97M sh · $1.48B · Q2 2026
- Northern Trust Corp 2.49M sh · $1.24B · Q2 2026